Welcome to industryreportstore.com

Need help? +44(0)20 7936 6830

Antibody Technologies market research, reports and industry analysis

mail

Contact us for professional industry advice

Email us or call

+44(0)20 7936 6830
mail

for FREE research alerts
to your inbox

9 Item(s)

Page 1 of 1

  1. Global Monoclonal Antibodies Market 2016-2020

    By: Technavio
    , Published: Jul-2016
    , Product code: IRTNTR9857
    The report covers the present scenario and the growth prospects of the global monoclonal antibodies (mAbs) market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded mAbs and biosimilars used to treat cancer, autoimmune and inflammatory diseases, respiratory diseases, and ophthalmology. It also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market, along with the decline in revenues from the patent expiries of the marketed drugs, during the forecast period.
    $2,500.00

  2. Global Body Contouring Market 2016-2020

    By: Technavio
    , Published: May-2016
    , Product code: IRTNTR9402
    The report covers the present scenario and the growth prospects of the Global Body Contouring Market for 2016-2020.
    $2,500.00

  3. Global Antibody Conjugates Drugs Market 2016-2020

    By: Technavio
    , Published: Mar-2016
    , Product code: IRTNTR8911
    The report covers the present scenario and the growth prospects of the global ADCs market for the period 2015-2020. To calculate the market size, the report considers revenue generated from the sales of ADCs used to treat cancer.
    $2,500.00

  4. Global Monoclonal Antibody Partnering Agreements - Mar2016

    By: Current Partnering
    , Published: Mar-2016
    , Product code: CP21131
    The Global Monoclonal Antibody Partnering Terms and Agreements 2010 to 2016 report provides comprehensive understanding and unprecedented access to the monoclonal antibodies partnering deals and agreements entered into by the worlds leading healthcare companies
    $2,995.00

  5. Global Antibody Partnering Agreements - Mar2016.pdf

    By: Current Partnering
    , Published: Mar-2016
    , Product code: CP2113
    The Global Antibody Partnering 2010-2016 report provides comprehensive understanding and unprecedented access to the antibody partnering deals and agreements entered into by the worlds leading healthcare companies
    $2,995.00

  6. Global Protein Therapeutics Market 2016-2020

    By: Technavio
    , Published: Nov-2015
    , Product code: IRTNTR8020
    Technavios market research analyst predicts the global protein therapeutics market to grow steadily at a CAGR of 8% during the forecast period. Increased demand for and use of monoclonal antibodies is expected to drive the growth of the protein therapeutics market as it accounts for more than half of the protein therapeutics market. The monoclonal antibodies can be prepared specific to any cell surface or extracellular target. These antibodies are being used in radioimmunotherapy and antibody-directed enzyme prodrug therapy. Monoclonal antibodies are also used in the formulation of various biopharmaceutical drugs for the treatment of different diseases such as cancer, rheumatoid arthritis, multiple sclerosis, and UC.
    $3,000.00

  7. Antibody Deals and Alliances of 2014

    By: Current Partnering
    , Published: Mar-2015
    , Product code: CP2024a
    A review of antibody partnering trends and comprehensive directory of deals and alliances announced during 2014
    $1,495.00

  8. Antibody Partnering Terms and Agreements

    By: Current Partnering
    , Published: Jan-2015
    , Product code: CP2113-
    The Antibody Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the antibody partnering deals and agreements entered into by the worlds leading healthcare companies.
    $2,995.00

  9. Global Antibiotics Market 2014-2018

    By: Technavio
    , Published: Sep-2014
    , Product code: IRTNTR4193
    About Antibiotics Antibacterial drugs are chemical compounds used to kill or inhibit the growth of bacteria. The term "antibiotic" is often used synonymously with antibacterial; however, the term "antibiotic" was originally coined to refer to the antibacterial compounds of microbial origin. Antibacterial acts via various mechanisms such as the inhibition of cell wall synthesis, the inhibition of nucleic acid synthesis, the disruption of the cell membrane, and the inhibition of protein synthesis. It can be bacteriostatic or bactericidal in nature. Antibiotics are medicines that are used to treat infections caused by bacteria (e.g., respiratory tract infections). Antibiotics work against microorganisms such as bacteria, fungi, and parasites but are not effective against viruses. Antibiotics either block vital processes in bacteria, kill the bacteria, or halt them from growing. Antibiotics that affect a wide range of bacteria are called broad spectrum antibiotics (e.g., amoxicillin and gentamicin). Antibiotics that affect only a few types of bacteria are called narrow spectrum antibiotics (e.g., penicillin).
    $2,500.00

9 Item(s)

Page 1 of 1